These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 20177738)
1. Cbl-b promotes chemotherapy-induced apoptosis in rat basophilic leukemia cells by suppressing PI3K/Akt activation and enhancing MEK/ERK activation. Qu X; Li Y; Liu J; Xu L; Zhang Y; Hu X; Hou K; Liu Y Mol Cell Biochem; 2010 Jul; 340(1-2):107-14. PubMed ID: 20177738 [TBL] [Abstract][Full Text] [Related]
2. Ubiquitin ligase Cbl-b sensitizes leukemia and gastric cancer cells to anthracyclines by activating the mitochondrial pathway and modulating Akt and ERK survival signals. Qu X; Zhang Y; Li Y; Hu X; Xu Y; Xu L; Hou K; Sada K; Liu Y FEBS Lett; 2009 Jul; 583(13):2255-62. PubMed ID: 19508871 [TBL] [Abstract][Full Text] [Related]
3. E3 ubiquitin ligase Cbl-b potentiates the apoptotic action of arsenic trioxide by inhibiting the PI3K/Akt pathway. Yingchun L; Xiujuan Q; Jinglei Q; Ye Z; Jing L; Yuee T; Xuejun H; Kezuo H; Yunpeng L Braz J Med Biol Res; 2011 Feb; 44(2):105-11. PubMed ID: 21180886 [TBL] [Abstract][Full Text] [Related]
4. Ubiquitin ligase c-Cbl is involved in tamoxifen-induced apoptosis of MCF-7 cells by downregulating the survival signals. Yan SC; Liu YP; Zhang LY; Qu JL; Xu L; Liu J; Zhang Y; Hou KZ; Teng YE; Qu XJ Acta Oncol; 2011 Jun; 50(5):693-9. PubMed ID: 21175263 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway but not the MEK/ERK pathway attenuates laminin-mediated small cell lung cancer cellular survival and resistance to imatinib mesylate or chemotherapy. Tsurutani J; West KA; Sayyah J; Gills JJ; Dennis PA Cancer Res; 2005 Sep; 65(18):8423-32. PubMed ID: 16166321 [TBL] [Abstract][Full Text] [Related]
6. Ubiquitin ligase Cbl-b represses IGF-I-induced epithelial mesenchymal transition via ZEB2 and microRNA-200c regulation in gastric cancer cells. Li H; Xu L; Li C; Zhao L; Ma Y; Zheng H; Li Z; Zhang Y; Wang R; Liu Y; Qu X Mol Cancer; 2014 Jun; 13():136. PubMed ID: 24885194 [TBL] [Abstract][Full Text] [Related]
7. Activation of Akt and ERK signalling pathways induced by etoposide confer chemoresistance in gastric cancer cells. Liu SQ; Yu JP; Yu HG; Lv P; Chen HL Dig Liver Dis; 2006 May; 38(5):310-8. PubMed ID: 16527552 [TBL] [Abstract][Full Text] [Related]
8. PI3K/Akt is involved in bufalin-induced apoptosis in gastric cancer cells. Li D; Qu X; Hou K; Zhang Y; Dong Q; Teng Y; Zhang J; Liu Y Anticancer Drugs; 2009 Jan; 20(1):59-64. PubMed ID: 19343001 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of phosphatidylinositol 3-kinase-Akt signaling blocks growth, promotes apoptosis, and enhances sensitivity of small cell lung cancer cells to chemotherapy. Krystal GW; Sulanke G; Litz J Mol Cancer Ther; 2002 Sep; 1(11):913-22. PubMed ID: 12481412 [TBL] [Abstract][Full Text] [Related]
10. Cbl participates in shikonin-induced apoptosis by negatively regulating phosphoinositide 3-kinase/protein kinase B signaling. Qu D; Xu XM; Zhang M; Jiang TS; Zhang Y; Li SQ Mol Med Rep; 2015 Jul; 12(1):1305-13. PubMed ID: 25815461 [TBL] [Abstract][Full Text] [Related]
11. PI3K/Akt-sensitive MEK-independent compensatory circuit of ERK activation in ER-positive PI3K-mutant T47D breast cancer cells. Aksamitiene E; Kholodenko BN; Kolch W; Hoek JB; Kiyatkin A Cell Signal; 2010 Sep; 22(9):1369-78. PubMed ID: 20471474 [TBL] [Abstract][Full Text] [Related]
12. Synthetic lethal interaction between PI3K/Akt/mTOR and Ras/MEK/ERK pathway inhibition in rhabdomyosarcoma. Guenther MK; Graab U; Fulda S Cancer Lett; 2013 Sep; 337(2):200-9. PubMed ID: 23684925 [TBL] [Abstract][Full Text] [Related]
13. Brain-derived neurotrophic factor prevents phencyclidine-induced apoptosis in developing brain by parallel activation of both the ERK and PI-3K/Akt pathways. Xia Y; Wang CZ; Liu J; Anastasio NC; Johnson KM Neuropharmacology; 2010 Feb; 58(2):330-6. PubMed ID: 19887077 [TBL] [Abstract][Full Text] [Related]
14. MEK-independent survival of B-RAFV600E melanoma cells selected for resistance to apoptosis induced by the RAF inhibitor PLX4720. Jiang CC; Lai F; Thorne RF; Yang F; Liu H; Hersey P; Zhang XD Clin Cancer Res; 2011 Feb; 17(4):721-30. PubMed ID: 21088259 [TBL] [Abstract][Full Text] [Related]
15. Nucleus pulposus cells upregulate PI3K/Akt and MEK/ERK signaling pathways under hypoxic conditions and resist apoptosis induced by serum withdrawal. Risbud MV; Fertala J; Vresilovic EJ; Albert TJ; Shapiro IM Spine (Phila Pa 1976); 2005 Apr; 30(8):882-9. PubMed ID: 15834331 [TBL] [Abstract][Full Text] [Related]
16. Signal transduction of MEK/ERK and PI3K/Akt activation by hypoxia/reoxygenation in renal epithelial cells. Kwon DS; Kwon CH; Kim JH; Woo JS; Jung JS; Kim YK Eur J Cell Biol; 2006 Nov; 85(11):1189-99. PubMed ID: 16860436 [TBL] [Abstract][Full Text] [Related]
17. Cbl-b and PI3K/Akt pathway are differently involved in oxygen-glucose deprivation preconditioning in PC12 cells. Zhang W; Yu H; Zou W; Wang YF; Liang XF; Zhang B; Kong JJ; Li P; Zhang DD; Yin L Chin Med J (Engl); 2013 Nov; 126(21):4132-8. PubMed ID: 24229686 [TBL] [Abstract][Full Text] [Related]
18. Casitas B-lineage lymphoma mutants activate AKT to induce transformation in cooperation with class III receptor tyrosine kinases. Polzer H; Janke H; Schmid D; Hiddemann W; Spiekermann K Exp Hematol; 2013 Mar; 41(3):271-80.e4. PubMed ID: 23127761 [TBL] [Abstract][Full Text] [Related]
19. Autocrine insulin-like growth factor-I signaling promotes growth and survival of human acute myeloid leukemia cells via the phosphoinositide 3-kinase/Akt pathway. Doepfner KT; Spertini O; Arcaro A Leukemia; 2007 Sep; 21(9):1921-30. PubMed ID: 17581609 [TBL] [Abstract][Full Text] [Related]
20. The role of E3 ubiquitin ligase Cbl proteins in interleukin-2-induced Jurkat T-cell activation. Zhao MF; Qu XJ; Qu JL; Jiang YH; Zhang Y; Hou KZ; Deng H; Liu YP Biomed Res Int; 2013; 2013():430861. PubMed ID: 23586039 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]